Unraveling the role of mitochondrial dysfunction and senescence on inhibition of tissue regeneration during spaceflight and amelioration by a novel countermeasure, PQQ.
Ended Grant For Research Awarded Last action
- Contract number
- 80NSSC23K0775
- Awardee
-
Rensselaer Polytechnic Institute UEI U5WBFKEBLMX3
- Awarding agency
-
Shared Services Center
National Aeronautics and Space Administration
- Obligated
- $0
Award facts
- Contract value 0% obligated
- $900,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- Not on record
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Other
- Place of performance
- Troy, NY, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $100,000 | |
| Funding Only Action | $50,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $123,501 | |
| Original award | $50,000 |
About this award
Rensselaer Polytechnic Institute (RPI) received a $900,000 research grant awarded on May 1, 2023, by a civilian federal agency to investigate the role of mitochondrial dysfunction and senescence in inhibiting tissue regeneration during spaceflight and to evaluate a novel countermeasure known as pyrroloquinoline quinone (PQQ). The contract, which runs through April 30, 2026, is structured as a research grant with no set-aside designation, reflecting RPI's competitive standing in the open federal marketplace. The work will be performed at RPI's facilities in Troy, New York, and represents the institution's continued engagement in biomedical research addressing the physiological challenges posed by long-duration spaceflight.
This award builds on RPI's established track record as a significant federal research institution with expertise spanning aerospace, biotechnology, and advanced materials science. The research aligns with broader federal initiatives to understand and mitigate the biological effects of spaceflight on human tissue regeneration, supporting both civilian space exploration objectives and the scientific understanding of cellular aging mechanisms. As a non-profit research university, RPI continues to leverage its capabilities across multiple federal agencies and funding mechanisms to advance critical research in STEM disciplines.
Quick answers
Who was awarded contract 80NSSC23K0775?
80NSSC23K0775 was awarded to Rensselaer Polytechnic Institute by Shared Services Center (National Aeronautics and Space Administration) on May 1, 2023.
How much is contract 80NSSC23K0775 worth?
The government has obligated $0 on 80NSSC23K0775. Its current value, with exercised options, is $900,000.
Was contract 80NSSC23K0775 competed?
The extent of competition for 80NSSC23K0775 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award